Business Description
Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.
Business History
Price Overview
Last updated: Jun 27, 2026 10:02am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -5.13
Total Equity: $205.41M
Shares: 49,533,819
Total Debt: $41.29M
Cash: $237.60M
EBITDA: -$97.98M
Total Debt: $41.29M
Cash: $237.60M
Revenue: $59.82M
Shares: 49,533,819
Revenue: $59.82M
Revenue: $59.82M
Revenue: $59.82M
Total Equity: $205.41M
Tax Rate: -0.1%
Equity: $205.41M
Total Debt: $41.29M
Cash: $237.60M
Current Liabilities: $37.98M
Long-Term Debt: $41.10M
Total Debt: $41.29M
Total Equity: $205.41M
Shares: 49,533,819
Shares: 49,533,819
CapEx: -$23.59M
Shares: 49,533,819
Stock Price: $26.43
Net Income: -$113.81M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 21, 2026 7:39pm (5d ago)| Metric | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $7.6M | $27.8M | $59.8M |
| Cost of Revenue | $0 | $0 | $18.3M | $27.5M | $35.6M |
| Gross Profit | $0 | $0 | -$10.7M | $362,000 | $24.2M |
| Operating Expenses | $29.3M | $32.7M | $69.8M | $85.4M | $130.6M |
| Operating Income | -$29.3M | -$32.7M | -$80.4M | -$85.1M | -$106.4M |
| Net Income | -$29.5M | -$34.1M | -$84.2M | -$94.1M | -$113.8M |
| EBITDA | -$28.8M | -$32.3M | -$73.7M | -$76.3M | -$98.0M |
| EPS | $-0.59 | $-0.69 | $-1.75 | $-2.04 | $-5.13 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 7:39pm (5d ago)| Metric | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $5.8M | $24.3M | $14.8M | $8.2M | $237.6M |
| Total Current Assets | $6.2M | $26.2M | $18.4M | $14.9M | $255.3M |
| Total Assets | $7.9M | $30.5M | $38.7M | $45.9M | $295.7M |
| Current Liabilities | $4.0M | $6.6M | $36.7M | $33.0M | $38.0M |
| Long-Term Debt | $0 | $20.2M | $17.3M | $42.5M | $41.1M |
| Total Liabilities | $4.0M | $28.8M | $156.2M | $255.3M | $90.3M |
| Total Equity | $3.9M | $1.8M | -$117.6M | -$209.4M | $205.4M |
| Retained Earnings | -$136.0M | -$170.1M | -$312.3M | -$406.4M | -$520.2M |
Cash Flow (Annual)
Last updated: Jun 21, 2026 7:39pm (5d ago)| Metric | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$30.3M | -$29.9M | -$69.6M | -$72.2M | -$77.6M |
| Capital Expenditure | $-232,000 | $-336,000 | -$15.5M | -$12.5M | -$23.6M |
| Free Cash Flow | -$30.5M | -$30.2M | -$85.1M | -$84.7M | -$101.2M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $-286,000 | $18.6M | $11.0M | -$6.7M | $229.3M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 8:46am (1h ago)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$93.0M $93.0M – $94.0M
|
$132.9M $132.7M – $133.0M
|
$191.1M $191.1M – $191.1M
|
$269.0M $263.9M – $272.1M
|
| EBITDA |
-$18.6M -$18.8M – -$18.6M
|
-$26.6M -$26.6M – -$26.5M
|
-$38.2M -$38.2M – -$38.2M
|
-$53.8M -$54.4M – -$52.8M
|
| Net Income |
-$115.8M -$117.5M – -$114.1M
|
-$107.7M -$119.3M – -$96.2M
|
-$99.0M -$103.0M – -$70.5M
|
-$59.9M -$65.6M – -$54.2M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 7:39pm (5d ago)| Metric | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | — | — | +264.5% | +115.1% |
| Gross Profit Growth | — | — | +103.4% | +6,587.8% |
| Operating Income Growth | -11.6% | -145.9% | -5.8% | -25.1% |
| Net Income Growth | -15.7% | -147.0% | -11.7% | -20.9% |
| EBITDA Growth | -12.1% | -128.1% | -3.5% | -28.4% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 8:46am (1h ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-15 | Webster Brian Daniel | S-Sale | 15,000.00 | $20.81 | $312,143 |
| 2026-06-03 | Moran Timothy P. | A-Award | 22,704.00 | $0.00 | $0 |
| 2026-06-03 | Ford Alfred J Jr | A-Award | 25,227.00 | $0.00 | $0 |
| 2026-06-03 | Mahboob Vaseem | A-Award | 25,227.00 | $0.00 | $0 |
| 2026-06-03 | Umberger Traci S | A-Award | 25,227.00 | $0.00 | $0 |
| 2026-06-03 | Webster Brian Daniel | A-Award | 75,681.00 | $0.00 | $0 |
| 2026-05-15 | Webster Brian Daniel | S-Sale | 8,155.00 | $20.53 | $167,412 |
| 2026-05-15 | Webster Brian Daniel | S-Sale | 6,845.00 | $21.46 | $146,918 |
| 2026-04-15 | Webster Brian Daniel | S-Sale | 15,000.00 | $20.04 | $300,671 |
| 2026-03-26 | COHEN RAYMOND W | P-Purchase | 10,000.00 | $19.98 | $199,800 |
| 2026-03-17 | Webster Brian Daniel | S-Sale | 15,000.00 | $20.27 | $304,124 |
| 2026-03-11 | Reilly Kevin C | A-Award | 8,300.00 | $0.00 | $0 |
| 2026-02-17 | Webster Brian Daniel | S-Sale | 11,635.00 | $25.39 | $295,456 |
| 2026-02-17 | Webster Brian Daniel | S-Sale | 3,272.00 | $26.29 | $86,036 |
| 2026-02-17 | Webster Brian Daniel | S-Sale | 93.00 | $27.18 | $2,528 |
| 2026-01-15 | Webster Brian Daniel | S-Sale | 15,000.00 | $22.80 | $342,024 |
| 2025-12-29 | Umberger Traci S | S-Sale | 10,500.00 | $26.69 | $280,201 |
| 2025-12-29 | Webster Brian Daniel | S-Sale | 15,000.00 | $26.59 | $398,847 |
| 2025-12-03 | Moran Timothy P. | A-Award | 19,557.00 | $0.00 | $0 |
| 2025-11-03 | Moran Timothy P. | 0.00 | $0.00 | $0 |
Narrative Economics
market-narrative step).